Lee Ainslie Haemonetics Corp Transaction History

Maverick Capital LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $432,711 - $518,415	6,074 New	6,074 $518,000
Q2 2020 Aug 14, 2020	SELL	$84.96 - $118.91 $294,216 - $411,785	-3,463 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $427,008 - $699,734	-5,744 Reduced 62.39%	3,463 $345,000
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $1.05 Million - $1.19 Million	9,207 New	9,207 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $10.5 Million - $12.4 Million	-89,560 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$81.74 - $120.34 $7.32 Million - $10.8 Million	89,560 New	89,560 $10.8 Million
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $1.89 Million - $2.43 Million	-20,830 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $1.87 Million - $2.39 Million	20,830 New	20,830 $2.39 Million

337

54.3M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.05B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.